Definium Therapeutics said its Phase 3 DT120 results in generalized anxiety disorder won PsychCongress’s 2026 Poster Award for Excellence in Psychiatry. The recognition adds to Phase 3 progress in major depressive disorder and strengthens its psychiatric pipeline.
published
Definium Therapeutics said its Phase 3 DT120 results in generalized anxiety disorder won PsychCongress’s 2026 Poster Award for Excellence in Psychiatry. The recognition adds to Phase 3 progress in major depressive disorder and strengthens its psychiatric pipel
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.